Aspirin Dosing for Acute Rheumatic Fever

Acute Phase Dosing (High-Dose)

The American Heart Association recommends an initial dose of 80-100 mg/kg/day divided into 4 daily doses during the acute inflammatory phase, providing anti-inflammatory and antipyretic effects, and continuing high-dose aspirin until the patient has been afebrile for 48-72 hours 1, 2
Some clinicians continue high-dose therapy until day 14 of illness and 48-72 hours after fever cessation, as recommended by the American College of Cardiology 1

The American Heart Association recommends reducing to 3-5 mg/kg/day as a single daily dose after fever resolution, providing antiplatelet effects to prevent thrombotic complications 1, 2
In patients without coronary abnormalities, the American College of Cardiology recommends continuing low-dose aspirin until 6-8 weeks after illness onset with documented normal coronary arteries 1

The American Heart Association recommends discontinuing aspirin during active influenza or varicella infection due to Reye syndrome risk, and substituting with clopidogrel or low-molecular-weight heparin during these intervals 2
The American Academy of Pediatrics recommends administering annual influenza vaccination to all children on long-term aspirin therapy 1

The American College of Rheumatology recommends avoiding aspirin in patients with active bleeding, significant bleeding risk, or platelet count ≤80,000/μl, due to increased risk of bleeding complications 3, 4
The American Heart Association recommends not using ibuprofen concurrently with aspirin in patients requiring antiplatelet effects, as ibuprofen antagonizes aspirin-induced platelet inhibition 1, 2

The American Heart Association recommends gastroprotection with proton pump inhibitor therapy when using high-dose aspirin 5
The American College of Cardiology suggests monitoring clinical symptoms, particularly murmurs and signs of heart failure, and C-reactive protein (CRP) levels to guide treatment duration 5, 6
The guideline recommends against using corticosteroids as first-line therapy for acute rheumatic carditis, reserving them for cases where aspirin or NSAIDs are contraindicated, severe carditis unresponsive to aspirin, or specific autoimmune contexts requiring immunosuppression 5, 6
The American Academy of Pediatrics advises annual influenza vaccination for children taking salicylates long-term to monitor for Reye syndrome risk 7, 8

Treatment with aspirin should continue for the full 8-12 week course, even if symptoms improve earlier, to prevent recurrence 5, 9

Tolmetin at 25 mg/kg/day is an effective alternative to aspirin, with comparable efficacy and fewer side effects, in cases of aspirin intolerance or toxicity 5, 6